Compound mutations in BCR-ABL1 are not major drivers of primary or secondary resistance to ponatinib in CP-CML patients
Titel:
Compound mutations in BCR-ABL1 are not major drivers of primary or secondary resistance to ponatinib in CP-CML patients
Auteur:
Deininger, Michael W. Hodgson, J. Graeme Shah, Neil P. Cortes, Jorge E. Kim, Dong-Wook Nicolini, Franck E. Talpaz, Moshe Baccarani, Michele Müller, Martin C. Li, Jin Parker, Wendy T. Lustgarten, Stephanie Clackson, Tim Haluska, Frank G. Guilhot, Francois Kantarjian, Hagop M. Soverini, Simona Hochhaus, Andreas Hughes, Timothy P. Rivera, Victor M. Branford, Susan